Clinical Trial Update: Assessment of Foralumab Safety and Modulation of Microglial Activation in Alzheimer's Disease [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial evaluating the safety and potential modulation of microglial activation by foralumab in Alzheimer's disease-related dementia. The study…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Alzheimer Disease
• Cognitive Impairment Due to Alzheimer Disease
• Dementia

Drugs mentioned

• Foralumab (Foralumab)

Snippet

Sponsor: Brigham and Women's Hospital | Conditions: Dementia, Alzheimers Disease | Phase 2 | Status: RECRUITING